IMPAX LABORATORIES, INC.

AVIBRIZ

Pharmaceuticals for the treatment of neurological disorders;

AVIBRIZ

Pharmaceuticals;

ELADUR

Surgical and medical materials, pharmaceuticals, preparations and apparatus for the relief of pain, namely, topical and transdermal compositions and tapes, plasters, adhesives and patches for delivery of analgesic and anesthetic agents to provide local and regional prevention of and or relief from pain; pharmaceutical transdermal patches for pain;

GLOBAL

pharmaceuticals, namely, promethazine, for treatment of allergic reactions and for control of nausea and vomiting; chloroquine, for treatment of malaria and extraintestinal amebiasis; prednisolone, for treatment of adrenocortical insufficiency, rheumatic disorders and collagen diseases; tetracycline, for treatment of infections caused by gram-negative microorganisms; methyltestosterone, for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone such as in delayed puberty; meprobamate, for management of anxiety disorders; hydrocortisone, for replacement therapy in adrenocortical therapy and as anti-inflammatory agent in disorders of many organ systems; hyoscyamine, for adjunctive therapy in treatment of peptic ulcer and for control of gastric secretion in spastic colitis; chlordiazepoxide, for relief of anxiety and tension; piperazine, for treatment of roundworms and pinworms; pancrealipase; for treatment of chronic pancreatitis and cystic fibrosis; vitamins and nutritional supplements, namely, calcium gluconate, ferrous gluconate, shark cartilage, melatonin, collagen and fish liver oil;

GLOBAL

The mark consists of a rectangle to the left with the left side of a stylized globe overlapping the right side of the rectangle and the word GLOBAL to the right of the globe.;a house mark for a full line of pharmaceutical preparations in tablet and capsule form;as to GLOBAL;Color is not claimed as a feature of the mark.;